Market Cap 11.47M
Revenue (ttm) 2.29M
Net Income (ttm) -18.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -813.54%
Debt to Equity Ratio 0.47
Volume 52,500
Avg Vol 69,498
Day's Range N/A - N/A
Shares Out 3.02M
Stochastic %K 30%
Beta -2.23
Analysts Strong Sell
Price Target $60.00

Company Profile

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual b...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 770 500 3910
Fax: 404 581 5903
Website: femasys.com
Address:
3950 Johns Creek Court, Suite 100, Suwanee, United States
4RiskyBusiness4
4RiskyBusiness4 Jun. 27 at 4:03 AM
$FEMY Doubled up n the $3.50’s. Sitting happy.
1 · Reply
MultiversalTruth
MultiversalTruth Jun. 26 at 5:06 PM
$NLST Femasys Inc. ($FEMY) formally regained compliance with Nasdaq's minimum bid price requirement on June 23, 2026, officially closing a listing deficiency. Looking forward to Netty getting back to the NAS!
2 · Reply
MIKEMB
MIKEMB Jun. 26 at 3:35 PM
$FEMY OMG it's going up....
0 · Reply
MultiversalTruth
MultiversalTruth Jun. 26 at 2:46 PM
$FEMY some basic Femasys history c/o AI search.. (for myself mostly) Previous Clinical Trials & Milestone Results The progression to the current final phase relies on two primary foundational stages: 1. The Stage 2 Ultrasound Feasibility Study (NCT04273594) The Study: A prospective, multi-center feasibility study. The Goal: Validated a new, non-radiation 3D/2D ultrasound confirmation test using Femasys' own FemVue diagnostic tool. This replaced traditional, invasive X-ray radiology exams (hysterosalpingography) to verify if the fallopian tubes were successfully blocked. Results: Successfully demonstrated that office-based ultrasound could reliably confirm tube occlusion. The trial protocol includes long-term safety monitoring for up to 68 months post-procedure.
4 · Reply
MIKEMB
MIKEMB Jun. 26 at 1:37 PM
$FEMY how much it will lose today?
0 · Reply
beaches911
beaches911 Jun. 26 at 5:50 AM
$FEMY she is probably baby trying to arrange a raise but it will be punishing to existing shareholders who want to invest in someone that is clearly mismanaging a company, this is the problem
1 · Reply
onethestiff
onethestiff Jun. 26 at 5:31 AM
$FEMY all it’s done since the RS is decline. It’s going to the gutter no news or anything.
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 25 at 9:25 PM
0 · Reply
Severian1
Severian1 Jun. 25 at 3:48 PM
$FEMY shop the damn company already
1 · Reply
Ked1977
Ked1977 Jun. 25 at 2:58 PM
$FEMY I sold yesterday and took some loss. I can’t stomach this stock anymore. Great product with idiots running it who don’t know how to plan and commercialize. Good luck to all.
1 · Reply
Latest News on FEMY
Femasys regains compliance with Nasdaq

2026-06-24T13:15:18.000Z - 4 days ago

Femasys regains compliance with Nasdaq


Femasys Regains Compliance with Nasdaq Listing Requirements

Jun 24, 2026, 9:00 AM EDT - 4 days ago

Femasys Regains Compliance with Nasdaq Listing Requirements


Femasys Inc trading halted, news pending

2026-06-05T23:55:32.000Z - 22 days ago

Femasys Inc trading halted, news pending


Femasys announces CE Mark approval for FemHSG Catheter

2026-05-13T14:46:53.000Z - 6 weeks ago

Femasys announces CE Mark approval for FemHSG Catheter


Femasys Slides: Corporate presentation

May 13, 2026, 7:00 AM EDT - 6 weeks ago

Femasys Slides: Corporate presentation


Femasys Quarterly report: Q1 2026

May 8, 2026, 8:00 AM EDT - 7 weeks ago

Femasys Quarterly report: Q1 2026


Femasys Earnings release: Q1 2026

May 8, 2026, 8:00 AM EDT - 7 weeks ago

Femasys Earnings release: Q1 2026


Femasys Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Femasys Proxy statement: Proxy filing


Femasys Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Femasys Proxy statement: Proxy filing


Femasys Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 2 months ago

Femasys Proxy statement: Proxy filing


Femasys Annual report: Q4 2025

Mar 31, 2026, 8:00 AM EDT - 3 months ago

Femasys Annual report: Q4 2025


Femasys Earnings release: Q4 2025

Mar 31, 2026, 8:00 AM EDT - 3 months ago

Femasys Earnings release: Q4 2025


Femasys Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 3 months ago

Femasys Proxy statement: Proxy filing


Femasys management to meet virtually with Lake Street

2026-03-24T15:20:53.000Z - 3 months ago

Femasys management to meet virtually with Lake Street


Femasys appoints Kenneth Eichenbaum to its Board of Directors

2026-03-18T13:05:27.000Z - 3 months ago

Femasys appoints Kenneth Eichenbaum to its Board of Directors


Femasys initiated with a Buy at Lake Street

2026-03-03T13:13:48.000Z - 4 months ago

Femasys initiated with a Buy at Lake Street


Femasys FemBloc achieved certification under MDSAP

2026-02-26T14:06:51.000Z - 4 months ago

Femasys FemBloc achieved certification under MDSAP


Femasys enters distribution partnership with OR Consulting

2026-02-03T14:20:28.000Z - 5 months ago

Femasys enters distribution partnership with OR Consulting


Femasys announces partnership with Refuah Health Center

2026-01-13T14:05:24.000Z - 5 months ago

Femasys announces partnership with Refuah Health Center


Femasys files to sell 68.42M shares of common stock for holders

2025-12-31T21:40:10.000Z - 6 months ago

Femasys files to sell 68.42M shares of common stock for holders


Femasys Registration statement: Registration filing

Dec 31, 2025, 7:00 AM EST - 6 months ago

Femasys Registration statement: Registration filing


Femasys secures U.S. FDA clearance for FemVue Controlled device

2025-12-18T14:21:29.000Z - 6 months ago

Femasys secures U.S. FDA clearance for FemVue Controlled device


Femasys Registration statement: Registration filing

Dec 4, 2025, 7:00 AM EST - 7 months ago

Femasys Registration statement: Registration filing


Femasys initiated with a Buy at Laidlaw

2025-11-20T10:00:27.000Z - 7 months ago

Femasys initiated with a Buy at Laidlaw


Femasys Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 8 months ago

Femasys Quarterly report: Q3 2025


Femasys Earnings release: Q3 2025

Nov 14, 2025, 7:00 AM EST - 8 months ago

Femasys Earnings release: Q3 2025


Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo

Oct 16, 2025, 9:00 AM EDT - 9 months ago

Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo


Femasys Registration statement: Registration filing

Aug 21, 2025, 8:00 AM EDT - 11 months ago

Femasys Registration statement: Registration filing


Femasys Registration statement: Registration filing

Aug 20, 2025, 8:00 AM EDT - 11 months ago

Femasys Registration statement: Registration filing


Femasys Announces Second Quarter Financial Results for 2025

Aug 8, 2025, 4:05 PM EDT - 11 months ago

Femasys Announces Second Quarter Financial Results for 2025


Femasys Quarterly report: Q2 2025

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Femasys Quarterly report: Q2 2025


Femasys Earnings release: Q2 2025

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Femasys Earnings release: Q2 2025


Femasys Registration statement: Registration filing

Jul 3, 2025, 8:00 AM EDT - 1 year ago

Femasys Registration statement: Registration filing


Femasys Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Quarterly report: Q1 2025


Femasys Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q1 2025


Femasys Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Femasys Proxy statement: Proxy filing


Femasys Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Femasys Proxy statement: Proxy filing


Femasys Annual report: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Femasys Annual report: Q4 2024


Femasys Earnings release: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q4 2024


Femasys Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Femasys Quarterly report: Q3 2024


Femasys Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Femasys Earnings release: Q3 2024


Femasys Quarterly report: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Femasys Quarterly report: Q2 2024


Femasys Earnings release: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Femasys Earnings release: Q2 2024


Femasys Proxy statement: Proxy filing

Jun 7, 2024, 8:00 AM EDT - 2 years ago

Femasys Proxy statement: Proxy filing


Femasys Quarterly report: Q1 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Femasys Quarterly report: Q1 2024


Femasys Earnings release: Q1 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Femasys Earnings release: Q1 2024


4RiskyBusiness4
4RiskyBusiness4 Jun. 27 at 4:03 AM
$FEMY Doubled up n the $3.50’s. Sitting happy.
1 · Reply
MultiversalTruth
MultiversalTruth Jun. 26 at 5:06 PM
$NLST Femasys Inc. ($FEMY) formally regained compliance with Nasdaq's minimum bid price requirement on June 23, 2026, officially closing a listing deficiency. Looking forward to Netty getting back to the NAS!
2 · Reply
MIKEMB
MIKEMB Jun. 26 at 3:35 PM
$FEMY OMG it's going up....
0 · Reply
MultiversalTruth
MultiversalTruth Jun. 26 at 2:46 PM
$FEMY some basic Femasys history c/o AI search.. (for myself mostly) Previous Clinical Trials & Milestone Results The progression to the current final phase relies on two primary foundational stages: 1. The Stage 2 Ultrasound Feasibility Study (NCT04273594) The Study: A prospective, multi-center feasibility study. The Goal: Validated a new, non-radiation 3D/2D ultrasound confirmation test using Femasys' own FemVue diagnostic tool. This replaced traditional, invasive X-ray radiology exams (hysterosalpingography) to verify if the fallopian tubes were successfully blocked. Results: Successfully demonstrated that office-based ultrasound could reliably confirm tube occlusion. The trial protocol includes long-term safety monitoring for up to 68 months post-procedure.
4 · Reply
MIKEMB
MIKEMB Jun. 26 at 1:37 PM
$FEMY how much it will lose today?
0 · Reply
beaches911
beaches911 Jun. 26 at 5:50 AM
$FEMY she is probably baby trying to arrange a raise but it will be punishing to existing shareholders who want to invest in someone that is clearly mismanaging a company, this is the problem
1 · Reply
onethestiff
onethestiff Jun. 26 at 5:31 AM
$FEMY all it’s done since the RS is decline. It’s going to the gutter no news or anything.
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 25 at 9:25 PM
0 · Reply
Severian1
Severian1 Jun. 25 at 3:48 PM
$FEMY shop the damn company already
1 · Reply
Ked1977
Ked1977 Jun. 25 at 2:58 PM
$FEMY I sold yesterday and took some loss. I can’t stomach this stock anymore. Great product with idiots running it who don’t know how to plan and commercialize. Good luck to all.
1 · Reply
Jptrader3
Jptrader3 Jun. 25 at 2:48 PM
$FEMY next news event with a spike will be paired with dilution to keep the lights on. Kathy needs to work on selling the company at this point. I’m hoping for breakeven at $16. I bought at 0.82 pre-reverse split thinking the worst was over.
0 · Reply
Jptrader3
Jptrader3 Jun. 25 at 2:25 PM
$ARBE buying more next week. I’ll be down 10k by the time this potentially bounces from the $0.50’s. I’m also getting fuc#% by $HUMA , $MDAI , $FEMY and $MBOT . I’m quitting my penny stock addiction whichever one of these hits $10. I can’t bear another reverse split 🥲
1 · Reply
onethestiff
onethestiff Jun. 25 at 2:00 PM
$FEMY market cap dropping.
0 · Reply
MIKEMB
MIKEMB Jun. 25 at 1:43 PM
$FEMY every day it lose worth.... bad investment
0 · Reply
onethestiff
onethestiff Jun. 25 at 1:30 PM
$FEMY let’s get ready for another day of disappointment
0 · Reply
onethestiff
onethestiff Jun. 25 at 1:10 AM
$FEMY here comes the fall back down. It’s done they had our money and ran.
0 · Reply
steve04240
steve04240 Jun. 25 at 12:23 AM
$FEMY does anyone want to try to convince me not to sell my shares?
4 · Reply
Severian1
Severian1 Jun. 24 at 11:06 PM
$FEMY hot news release!!! we retained two directors and lined up an auditor!!!! lets go!!!!!!!!🚀🚀🚀🚀🚀🚀🚀
1 · Reply
Severian1
Severian1 Jun. 24 at 11:05 PM
$FEMY limbo challenge right now🤣
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 24 at 9:12 PM
1 · Reply
steve04240
steve04240 Jun. 24 at 8:24 PM
$FEMY this is fuckin crazy
0 · Reply
beaches911
beaches911 Jun. 24 at 8:09 PM
$FEMY looks like raisexwill be in the 2’s now
0 · Reply